NASDAQ · Healthcare · Biotechnology
Artiva Biotherapeutics, Inc.
ARTV
Artiva Biotherapeutics, Inc. CEO Fred Aslan · Market cap $559.8M.
$11.45
+0.15 · +1.33%
52w hi $14.5352w lo $2.22
Off 52w high 30.5%
60
NOTABLE
Current InsiderScore
Corp · 90d
17
17 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
9
1 strong · 8 notable
Analyst consensus
Strong Buy
Avg PT $37.50
Section 01
Recent Form 4 filings
20 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jul 31 | RA CAPITAL MANAGEMENT, L.P. | Buy | 24,944 | $9.93 | +$248K | 54 | |
| Jul 29 | RA CAPITAL MANAGEMENT, L.P. | Buy | 20,824 | $9.99 | +$208K | 54 | |
| Jul 24 | RA CAPITAL MANAGEMENT, L.P. | Buy | 41,319 | $9.99 | +$413K | 54 | |
| Jul 23 | RA CAPITAL MANAGEMENT, L.P. | Buy | 59,880 | $9.96 | +$596K | 57 | |
| Jul 22 | RA CAPITAL MANAGEMENT, L.P. | Buy | 84,124 | $9.93 | +$835K | 57 | |
| Jul 21 | RA CAPITAL MANAGEMENT, L.P. | Buy | 120,582 | $9.55 | +$1.15M | 60 | |
| Jul 17 | RA CAPITAL MANAGEMENT, L.P. | Buy | 7,882 | $8.95 | +$71K | 37 | |
| Jul 16 | RA CAPITAL MANAGEMENT, L.P. | Buy | 152,472 | $8.93 | +$1.36M | 60 | |
| Jul 13 | RA CAPITAL MANAGEMENT, L.P. | Buy | 6,552 | $8.94 | +$59K | 37 | |
| Jul 13 | RA CAPITAL MANAGEMENT, L.P. | Buy | 6,522 | $8.94 | +$58K | 37 | |
| Jul 10 | RA CAPITAL MANAGEMENT, L.P. | Buy | 15,102 | $8.97 | +$135K | 54 | |
| Jun 25 | RA CAPITAL MANAGEMENT, L.P. | Buy | 31,000 | $8.88 | +$275K | 54 | |
| Jun 16 | RA CAPITAL MANAGEMENT, L.P. | Buy | 124,893 | $8.89 | +$1.11M | 60 | |
| Jun 15 | RA CAPITAL MANAGEMENT, L.P. | Buy | 15,414 | $8.99 | +$139K | 54 | |
| Jun 12 | RA CAPITAL MANAGEMENT, L.P. | Buy | 391,019 | $8.57 | +$3.35M | 60 | |
| Jun 11 | RA CAPITAL MANAGEMENT, L.P. | Buy | 548,580 | $7.91 | +$4.34M | 60 | |
| Jun 09 | RA CAPITAL MANAGEMENT, L.P. | Buy | 479,039 | $6.91 | +$3.31M | 60 | |
| May 11 | RA CAPITAL MANAGEMENT, L.P. | Buy | 6,510,416 | $11.52 | +$75.00M | 78 | |
| May 11 | GC Corp. | Buy | 1,085,069 | $11.52 | +$12.50M | 73 | |
| May 11 | GC Corp. | Buy | 347,222 | $11.52 | +$4.00M | 70 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug